The Study of Bacteriology and Pathogen Drug Sensitivity of Chronic Dacryocystitis

July 26, 2017 updated by: Wang Zhichong, Sun Yat-sen University
An observational study was designed to research the bacteriology and pathogen drug sensitivity of chronic dacryocystitis in China and optimize antibiotic therapy.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

For patients diagnosed with chronic dacryocystitis，we will collect the secretions after lacrimal passage irrigation, note the characters of the secretions and send the secretions for bacteria culture, analysis and pathogen drug sensitivity.

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Guangdong
      • Guangzhou, Guangdong, China, 510000
        • Recruiting
        • Clinical Research Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study will be conducted among patients with chronic dacryocystitis attending Zhongshan Ophthalmic Center.

Description

Inclusion Criteria:

  1. Diagnosed with chronic dacryocystitis
  2. No involvement in other drug experiment in the past 1 week

Exclusion Criteria:

  1. Can not cooperate the specimen collection
  2. With any other eye disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bacterial agents
Time Frame: 2 weeks
Specimens will be collected after irrigation of the lacrimal passage and be sent for bacterial culture and bacterial analysis.
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sensitivity test
Time Frame: 2 weeks
The drugs tested include Penicilin, Amikacin, Azithromycin, Cefoxitin, Levofloxacin，Ofloxacin, Cefuroxime and Tobramycin.
2 weeks
The colour of lacrimal sac secretion
Time Frame: 2 weeks
The colour of lacrimal sac secretion will be identified by the doctor during the irrigation of the lacrimal passage.
2 weeks
The character of lacrimal sac secretion
Time Frame: 2 weeks
The lacrimal sac secretion will be classified as mucus or pus.
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sun Yat-sen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 17, 2017

Primary Completion (ANTICIPATED)

April 17, 2018

Study Completion (ANTICIPATED)

April 17, 2018

Study Registration Dates

First Submitted

July 7, 2017

First Submitted That Met QC Criteria

July 12, 2017

First Posted (ACTUAL)

July 13, 2017

Study Record Updates

Last Update Posted (ACTUAL)

July 27, 2017

Last Update Submitted That Met QC Criteria

July 26, 2017

Last Verified

July 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2017019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dacryocystitis

Clinical Trials on bacterial culture and analysis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe